Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2025-12-25 @ 7:39 PM
Study NCT ID:
NCT04991532
Status:
UNKNOWN
Last Update Posted:
2021-08-05
First Post:
2021-08-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Dasatinib Down-regulates the Expression of PD-1 and Enhances Killing pH + Leukemia Stem Cells
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-03
First Submit QC Date:
None
Study First Post Date:
2021-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-04
Last Update Post Date:
2021-08-05
Last Update Post Date Type:
ACTUAL